X. Pedre, F. Mastronardi, W. Bruck, G. López-Rodas, T. Kuhlmann, P. Casaccia. Changed histone acetylation patterns in normal-appearing white matter and early multiple sclerosis lesions. The Journal of neuroscience : […]
N.S. Mattan, C.A. Ghiani, M. Lloyd, R. Matalon, D. Bok, P. Casaccia, J.d. Vellis. Aspartoacylase deficiency affects early postnatal development of oligodendrocytes and myelination. Neurobiology of disease, 2010 Nov;40(2):432-43.. DOI: […]
J. Liu, J. Sandoval, S.T. Doh, L. Cai, G. López-Rodas, P. Casaccia. Epigenetic modifiers are necessary but not sufficient for reprogramming non-myelinating cells into myelin gene-expressing cells. PloS one, 2010 […]
J.Y. Kim, P. Casaccia. HDAC1 in axonal degeneration: A matter of subcellular localization. Cell cycle (Georgetown, Tex.), 2010 Sep 15;9(18):3680-4.. DOI: doi.org/10.4161/cc.9.18.12716 […]
K.C. Dietz, P. Casaccia. HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacological research, 2010 Jul;62(1):11-7.. DOI: doi.org/10.1016/j.phrs.2010.01.011 […]
J.L. Huynh, P. Casaccia. Defining the chromatin landscape in demyelinating disorders. Neurobiology of disease, 2010 Jul;39(1):47-52.. DOI: doi.org/10.1016/j.nbd.2009.10.014 […]
D. Kerns, G.S. Vong, K. Barley, S. Dracheva, P. Katsel, P. Casaccia, V. Haroutunian, W. Byne. Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia. Schizophrenia research, […]
I. Germano, V. Swiss, P. Casaccia. Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?. Neuropharmacology, 2010 May;58(6):903-10.. DOI: doi.org/10.1016/j.neuropharm.2009.12.019 […]
J. Liu, P. Casaccia. Epigenetic regulation of oligodendrocyte identity. Trends in neurosciences, 2010 Apr;33(4):193-201.. DOI: doi.org/10.1016/j.tins.2010.01.007 […]
V.A. Swiss, P. Casaccia. Cell-context specific role of the E2F/Rb pathway in development and disease. Glia, 2010 Mar;58(4):377-90.. DOI: doi.org/10.1002/glia.20933 […]